215 related articles for article (PubMed ID: 9534954)
1. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus.
Sáiz JC; López-Labrador FX; Ampurdanés S; Dopazo J; Forns X; Sánchez-Tapias JM; Rodés J
J Infect Dis; 1998 Apr; 177(4):839-47. PubMed ID: 9534954
[TBL] [Abstract][Full Text] [Related]
2. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
Pawlotsky JM; Germanidis G; Neumann AU; Pellerin M; Frainais PO; Dhumeaux D
J Virol; 1998 Apr; 72(4):2795-805. PubMed ID: 9525599
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.
Squadrito G; Leone F; Sartori M; Nalpas B; Berthelot P; Raimondo G; Pol S; Bréchot C
Gastroenterology; 1997 Aug; 113(2):567-72. PubMed ID: 9247477
[TBL] [Abstract][Full Text] [Related]
4. Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?
Squadrito G; Raffa G; Restuccia T; Pollicino T; Brancatelli S; Raimondo G
J Viral Hepat; 2002 Sep; 9(5):360-9. PubMed ID: 12225331
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.
Bagaglio S; Bruno R; Lodrini S; De Mitri MS; Andreone P; Loggi E; Galli L; Lazzarin A; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):153-61. PubMed ID: 14518715
[TBL] [Abstract][Full Text] [Related]
6. Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon and ribavirin.
Jardim AC; Yamasaki LH; de Queiróz AT; Bittar C; Pinho JR; Carareto CM; Rahal P; Mello IM
Infect Genet Evol; 2009 Jul; 9(4):689-98. PubMed ID: 19063998
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus.
Chung RT; Monto A; Dienstag JL; Kaplan LM
J Med Virol; 1999 Aug; 58(4):353-8. PubMed ID: 10421401
[TBL] [Abstract][Full Text] [Related]
8. Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.
Veillon P; Payan C; Le Guillou-Guillemette H; Gaudy C; Lunel F
World J Gastroenterol; 2007 Feb; 13(8):1195-203. PubMed ID: 17451199
[TBL] [Abstract][Full Text] [Related]
9. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
Nousbaum J; Polyak SJ; Ray SC; Sullivan DG; Larson AM; Carithers RL; Gretch DR
J Virol; 2000 Oct; 74(19):9028-38. PubMed ID: 10982347
[TBL] [Abstract][Full Text] [Related]
10. Mutations in ISDR of NS5A gene influence interferon efficacy in Chinese patients with chronic hepatitis C virus genotype 1b infection.
Shen C; Hu T; Shen L; Gao L; Xie W; Zhang J
J Gastroenterol Hepatol; 2007 Nov; 22(11):1898-903. PubMed ID: 17914967
[TBL] [Abstract][Full Text] [Related]
11. Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-alpha.
Gerotto M; Dal Pero F; Sullivan DG; Chemello L; Cavalletto L; Polyak SJ; Pontisso P; Gretch DR; Alberti A
J Viral Hepat; 1999 Sep; 6(5):367-72. PubMed ID: 10607252
[TBL] [Abstract][Full Text] [Related]
12. The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
Brillet R; Penin F; Hezode C; Chouteau P; Dhumeaux D; Pawlotsky JM
J Infect Dis; 2007 Feb; 195(3):432-41. PubMed ID: 17205483
[TBL] [Abstract][Full Text] [Related]
13. Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C.
Puig-Basagoiti F; Sáiz JC; Forns X; Ampurdanès S; Giménez-Barcons M; Franco S; Sánchez-Fueyo A; Costa J; Sánchez-Tapias JM; Rodés J
J Med Virol; 2001 Sep; 65(1):35-44. PubMed ID: 11505441
[TBL] [Abstract][Full Text] [Related]
14. Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.
Kobayashi M; Watanabe K; Ishigami M; Murase K; Ito H; Ukai K; Yano M; Takagi K; Hattori M; Kakumu S; Yoshioka K
Am J Gastroenterol; 2002 Apr; 97(4):988-98. PubMed ID: 12003437
[TBL] [Abstract][Full Text] [Related]
15. Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection.
Murakami T; Enomoto N; Kurosaki M; Izumi N; Marumo F; Sato C
Hepatology; 1999 Oct; 30(4):1045-53. PubMed ID: 10498658
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Zeuzem S; Lee JH; Roth WK
Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
[TBL] [Abstract][Full Text] [Related]
17. [Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin].
Veillon P; Payan C; Gaudy C; Goudeau A; Lunel F
Pathol Biol (Paris); 2004 Nov; 52(9):505-10. PubMed ID: 15531113
[TBL] [Abstract][Full Text] [Related]
18. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
Yoshioka K; Ito H; Watanabe K; Yano M; Ishigami M; Mizutani T; Sasaki Y; Goto H
J Viral Hepat; 2005 Mar; 12(2):139-45. PubMed ID: 15720528
[TBL] [Abstract][Full Text] [Related]
19. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients.
Khorsi H; Castelain S; Wyseur A; Izopet J; Canva V; Rombout A; Capron D; Capron JP; Lunel F; Stuyver L; Duverlie G
J Hepatol; 1997 Jul; 27(1):72-7. PubMed ID: 9252076
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations.
Durante Mangoni E; Forton DM; Ruggiero G; Karayiannis P
J Med Virol; 2003 May; 70(1):62-73. PubMed ID: 12629645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
